Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

ProBioGen AG

www.probiogen.de

Goethestrasse 54
Berlin
13086
Germany

+49 30 924 006-0

Activities

Manufacturing | Research & Development | Pharmaceutical

Related Companies

  • Lonza
  • Titan Enterprises
  • Icrom SRL
  • TrakCel
  • Huber
  • Nanoform
  • GEA Pharma and Healthcare
  • Merck Life Science KGaA
  • Starlab
  • Adare Pharma Solutions
  • Beamex
  • Edwards Vacuum
  • Burkert Fluid Control Systems
  • Envair Technology
  • Biopharma Group
  • Asynt
  • PCI Pharma Services
  • Owen Mumford
  • Watson Marlow Fluid Technology Solutions
  • Curia

Related Content

ProBioGen enters technology collaboration with Boehringer Ingelheim
ProBioGen enters technology collaboration with Boehringer Ingelheim
ProBioGen and Thermo Fisher Scientific team up on cell platform
ProBioGen and Thermo Fisher Scientific team up on cell platform
ProBioGen and City of Hope announce commercial licence for manufacturing
ProBioGen and City of Hope announce commercial licence for manufacturing
ProBioGen chooses NextPoint for GMP manufacturing of antibody
ProBioGen chooses NextPoint for GMP manufacturing of antibody
ProBioGen teams up with Granite Bio for cell line development and GMP manufacturing services
ProBioGen teams up with Granite Bio for cell line development and GMP manufacturing services
AstraZeneca licenses GlymaxX tech for drug discovery
AstraZeneca licenses GlymaxX tech for drug discovery
Innovent licenses ProBioGen’s GlymaxX technology
Innovent licenses ProBioGen’s GlymaxX technology
ProBioGen platform reaches Phase III clinical development
ProBioGen platform reaches Phase III clinical development
ProBioGen gets green light for cell line tech research license
ProBioGen gets green light for cell line tech research license
Nobelpharma licenses ProBioGen’s AGE1.CR.pIX vaccine platform
Nobelpharma licenses ProBioGen’s AGE1.CR.pIX vaccine platform
ValenzaBio licences ProBioGen’s GlymaxX technology
ValenzaBio licences ProBioGen’s GlymaxX technology
ProBioGen and Heat Biologics enter research licence agreement
ProBioGen and Heat Biologics enter research licence agreement
ProBioGen and LAVA Therapeutics sign cell line agreement
ProBioGen and LAVA Therapeutics sign cell line agreement
ProBioGen and Minapharm incorporate subsidiary
ProBioGen and Minapharm incorporate subsidiary
Asher contracts ProBioGen to develop lead candidate
Asher contracts ProBioGen to develop lead candidate
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company